| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2025 | 15 May 2025 |
| Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve financial results for the quarter and year ended March 31 2025 and any other matter with the permission of chair. The Board Meeting to be held on 23/05/2025 has been revised to 30/05/2025 The Board Meeting to be held on 23/05/2025 has been revised to 30/05/2025 due to certain exigencies. (As per BSE Announcement Dated on 21/05/2025) Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on May 30, 2025. (As Per BSE Announcement Dated on: 30/05/2025) | ||
| Board Meeting | 14 Feb 2025 | 7 Feb 2025 |
| AURO LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1. Unaudited Financial Results of the Company for quarter ended December 31 2024 along with Limited Review Report thereon. 2. Any other matter with the permission of the Chair. Attached herewith Unaudited Financial Results of the company for the Quarter ended December 31, 2024. (As Per BSE Announcement Dated on: 14/02/2025) | ||
| Board Meeting | 11 Nov 2024 | 5 Nov 2024 |
| AURO LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024 along with Limited Review Report and any other matter with the permission of the Chair. | ||
| Board Meeting | 9 Aug 2024 | 31 Jul 2024 |
| AURO LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve 1. Unaudited Financial Results of the Company for quarter ended June 30 2024 along with Limited Review Report thereon. 2. Any other matter with the permission of the Chair. Pursuant to Regulation 30 & 33 of the SEBI(LODR), Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their Meeting held today (i.e. Friday, August 09, 2024) inter alia, considered and approved Unaudited Financials Results for the quarter ended June 30, 2024 along with Limited Review Report received from the Statutory Auditor of the Company. (As per BSE Announcement Dated on 09/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.